Chandrashekhar Athare: EHA 2026 Concludes with Lasting Impact and New Collaborations
Chandrashekhar Athare, Associate Director at Innomagine Consulting Private Limited, shared a post on LinkedIn:
“As EHA 2026 comes to a close, I would like to express my gratitude to the organizers, speakers, exhibitors, and fellow attendees for an excellent congress in Stockholm.
Over the past few days, I had the opportunity to learn about the latest advancements in hematology, attend inspiring scientific sessions, and connect with professionals from across the global healthcare and life sciences community.
The insights gained, conversations shared, and connections made will undoubtedly contribute to future collaborations and continued learning.
A special thanks to everyone who took the time to connect and exchange ideas.
I look forward to staying in touch and continuing these discussions beyond the congress.
Until next time—looking forward to EHA 2027!”
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 10:49Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
-
Jun 15, 2026, 10:49Marek Mráz: A Landmark EHA 2026 for Our Lab
-
Jun 15, 2026, 10:32Magnus Ek: Operational Excellence in Delivering Seamless Access for 17,000 Delegates at EHA 2026 Congress
-
Jun 15, 2026, 10:15Carol Bewick: Why the Global Community Makes EHA 2026 Unforgettable
-
Jun 15, 2026, 10:07Habib Bennaceur: Driving Haemoglobinopathies Progress Across Multiple Clinical Programmes At EHA 2026
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026